912331-75-0Relevant academic research and scientific papers
Picolinic acids as β-exosite inhibitors of botulinum neurotoxin A light chain
Bremer, Paul T.,Xue, Song,Janda, Kim D.
supporting information, p. 12521 - 12524 (2016/10/24)
In developing small-molecule inhibitors of botulinum neurotoxin serotype A light chain (BoNT/A LC), substituted picolinic acids were identified. Extensive investigation into the SAR of the picolinic acid scaffold revealed 5-(1-butyl-4-chloro-1H-indol-2-yl)picolinic acid (CBIP), which possessed low micromolar activity against BoNT/A. Kinetic and docking studies demonstrated binding of CBIP to the β-exosite: a largely unexplored site on the LC that holds therapeutic relevance for botulism treatment.
IMIDAZOPYRIDAZINE COMPOUNDS
-
Page/Page column 66, (2008/06/13)
The present invention relates to novel substituted imidazo[1,2-b] pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
